Realistic expectation: users typically see appetite reduction and measurable weight changes within weeks, while full effects develop over months
GLP-1RA therapy could provide a special advantage to patients with multiple risk factors for cardiometabolic diseases such as obesity, hypertension, dyslipidemia and documented atherosclerotic cardiovascular disease
And as you've all heard before, we have sensors on our tongue and elsewhere in our mouth that detect the various chemicals contained within food and lead to the senses of taste, which we call bitter, sweet, umami, salty, and sour
If you have dosed consistently through a fair trial window and genuinely see nothing, that is a reason to talk to your provider, not a reason to quietly increase the dose